---
title: "Eli Lilly completes acquisition of Adverum Biotechnologies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/269103582.md"
description: "Eli Lilly completes acquisition of Adverum Biotechnologies"
datetime: "2025-12-09T14:46:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269103582.md)
  - [en](https://longbridge.com/en/news/269103582.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269103582.md)
generator: "portal-rs"
---

# Eli Lilly completes acquisition of Adverum Biotechnologies


### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [ADVM.US](https://longbridge.com/en/quote/ADVM.US.md)

## Related News & Research

- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)
- [Oracle, Alphabet, Valero Energy And More On CNBC’s ‘Final Trades’](https://longbridge.com/en/news/297907685.md)
- [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md)
- [Delek US EVP Special Projects Reuven Spiegel sells 7,500 shares worth $549,092.50](https://longbridge.com/en/news/297970639.md)
- [Illumina (ILMN) Stock Looks Cheap On Cash Flow Yet Pricey On Earnings](https://longbridge.com/en/news/297785097.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**